Cargando…
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
Natural killer (NK) cell is a powerful malignant cells killer, providing rapid immune responses via direct cytotoxicity without the need of antigen processing and presentation. It plays an essential role in preventing early tumor, metastasis and minimal residual disease. Although adoptive NK therapi...
Autores principales: | Lian, Guangyu, Mak, Thomas Shiu-Kwong, Yu, Xueqing, Lan, Hui-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745474/ https://www.ncbi.nlm.nih.gov/pubmed/35008589 http://dx.doi.org/10.3390/ijms23010164 |
Ejemplares similares
-
Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023) -
Advances and challenges of immunotherapies in NK/T cell lymphomas
por: He, Ling, et al.
Publicado: (2023) -
The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
por: Kang, Synat, et al.
Publicado: (2021) -
Recent advances and challenges of bispecific antibodies in solid tumors
por: Wu, Yuze, et al.
Publicado: (2021) -
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)